NCT05169333 The Oxford Risk Factors And Non-Invasive Imaging Study
| NCT ID | NCT05169333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 250,000 participants |
| Start Date | 2016-02-23 |
| Primary Completion | 2030-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250,000 participants in total. It began in 2016-02-23 with a primary completion date of 2030-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility Criteria
Inclusion Criteria: Inclusion Criteria for study Arms 1, 2 and 3: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 -99 years. Inclusion Criteria for study Arm 4: • Male or Female, aged 18 -99 years. Exclusion Criteria: Exclusion Criteria for Study Arms 1, 2 and 3: * Unable or unwilling to consent * Active cancer Exclusion Criteria for Study Arm 4: * Participation in Study Arms 1, 2 or 3 * Existing opt-out from use of data for research purposes
Contact & Investigator
Kenneth Chan
✉ kenneth.chan@cardiov.ox.ac.ukAntoniades
PRINCIPAL INVESTIGATOR
University of Oxford
Frequently Asked Questions
Who can join the NCT05169333 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05169333 currently recruiting?
Yes, NCT05169333 is actively recruiting participants. Contact the research team at kenneth.chan@cardiov.ox.ac.uk for enrollment information.
Where is the NCT05169333 trial being conducted?
This trial is being conducted at Bethesda, United States, Rochester, United States, Cleveland, United States, Adelaide, Australia and 11 additional locations.
Who is sponsoring the NCT05169333 clinical trial?
NCT05169333 is sponsored by University of Oxford. The principal investigator is Antoniades at University of Oxford. The trial plans to enroll 250,000 participants.